Evidence-based recommendations for the use of antiemetics in radiotherapy

Radiotherapy and Oncology

Volumn 76, Issue 3, 2005, Pages 227-233

  Maranzano, Ernesto ^a   Feyer, Petra Ch ^b   Molassiotis, Alexander ^c   Rossi, Romina ^a   Clark Snow, Rebecca A ^d   Olver, Ian ^e   Warr, David ^f   Schiavone, Concetta ^g   Roila, Fausto ^h  

^a S MARIA HOSPITAL   (Italy)

^b VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF KANSAS CANCER CENTER   (United States)

^e UNIVERSITY OF ADELAIDE   (Australia)

^f PRINCESS MARGARET HOSPITAL   (Canada)

^g Radiation Oncology Service   (Italy)

^h Ospedale Silvestrini   (Italy)

Author keywords

Antiemetics; Emesis; Radiotherapy

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; DEXAMETHASONE; SEROTONIN 3 ANTAGONIST;

BREAST; CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RISK; CHEMOTHERAPY INDUCED EMESIS; CLINICAL PRACTICE; CONFERENCE PAPER; CONSENSUS; EVIDENCE BASED MEDICINE; HEAD; HUMAN; LIMB; MEDICAL LITERATURE; MEDICAL SOCIETY; NECK; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION INDUCED EMESIS; RADIOSURGERY; SKULL; VOMITING; WHOLE BODY RADIATION;

ANTIEMETICS; EVIDENCE-BASED MEDICINE; HUMANS; PRACTICE GUIDELINES; RADIOTHERAPY; RISK ASSESSMENT; SOCIETIES, MEDICAL; VOMITING;

EID: 25844477706     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2005.07.002     Document Type: Conference Paper

References (33)

1. N. Aass, D.E. Hatun, M. Thoresen, and S.D. Fossa Prophylactic use of tropisetron or metoclopramide during adjuvant abdominal radiotherapy of seminoma stage I: a randomised, open trial in 23 patients Radiother Oncol 45 1997 125 128
2. Antiemetic subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC) Prevention of chemotherapy- and radiotherapy-induced emesis: results of the Perugia consensus conference Ann Oncol 9 1998 811 819
3. P. Bey, P.M. Wilkinson, M. Resbeut, S. Bourdin, O. Le Floch, and W. Hahne A double-blind, placebo-controlled trial of i.v. dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting in cancer patients Support Care Cancer 4 1996 278 283
4. S. Bodis, E. Alexander 3rd, H. Kooy, and J.S. Loeffler The prevention of radiosurgery-induced nausea and vomiting by ondansetron: evidence of a direct effect on the central nervous system chemoreceptor trigger zone Surg Neurol 42 1994 249 252
5. C.P. Feyer, O.J. Titlbach, J. Wilkinson, and V. Budach Gastrointestinal reactions in radiotherapy (Abstr.) Support Care Cancer 4 1996 249
6. P.C. Feyer, A.L. Stewart, and O.J. Titlbach Aetiology and prevention of emesis induced by radiotherapy Support Care Cancer 6 1998 253 260
7. P.C. Feyer, and M.H. Seegenschmiedt Antiemetic patterns of care for radiotherapy-induced nausea and vomiting (Abstr. 929) Eur J Cancer 1 Suppl. 2003 279
8. L. Franzen, J. Nyman, H. Hagberg, M. Jakobsson, B. Sorbe, and A.L. Nyth A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy Ann Oncol 7 1996 587 592
9. B. Goldsmith Antiemetic patterns of care for radiotherapy-induced nausea and vomiting (Abstr.) Proc Am Soc Clin Oncol (ASCO) 22 2003 740
10. R. Gralla, D. Osaba, M.G. Kris, P. Kirkbride, P.J. Hesketh, and L.W. Chinnery For the American society of clinical oncology: recommendations for the use of the antiemetics: evidence-based, clinical practice guidelines J Clin Oncol 9 1999 2971 2994
11. P. Kirkbride, A. Bezjak, J. Pater, B. Zee, M.J. Palmer, and R. Wong Dexamethasone for the prophylaxis of radiation-induced emesis: a national cancer institute of Canada clinical trials group phase III study J Clin Oncol 18 2000 1960 1966
12. R. Lanciano, D.M. Sherman, J. Michalski, A.J. Preston, K. Yocom, and C. Friedman The efficacy and safety of once-daily kytril (granisetron hydrochloride) tablets in the prophylaxis of nausea and emesis following fractionated upper abdominal radiotherapy Cancer Invest 19 2001 763 772
13. J.P. LeBourgeois, C.J. McKenna, B. Coster, P. Feyer, L. Franzen, and L. Goedhals Efficacy of ondansetron orally disintegrating tablets: a novel oral formulation of this 5-HT3 receptor antagonist in the treatment of fractionated radiotherapy-induced nausea and emesis Clin Oncol 11 1995 340 347
14. L.C. Lewis, C. Flynn, and G. Boyea Phase III prospective randomised clinical trial utilizing oral granisetron hydrochloride (Kytril) for control of radiation induced nausea and vomiting when treating the abdomino/pelvic area Int J Radiat Oncol Biol Phys 54 Suppl. 2002 306
15. H.H. Lucraft, and M.K. Palmer Randomized clinical trial of levonantrodol and chlorpromazine in prevention of radiotherapy-induced vomiting Clin Radiol 33 1982 621 622
16. E. Maranzano, F. Roila, and V. De Angelis For the Italian group for antiemetic research in radiotherapy. Vomiting/nausea and diarrhea in radiotherapy: a prospective observational Italian trial (Abstr.) Radiother Oncol 48 1S 1998 181
17. E. Maranzano Radiation-induced emesis: a problem with many open questions Tumori 87 2001 213 218
18. E. Maranzano Prophylaxis of radiation-induced emesis J. Donnerer Antiemetic therapy 2003 Karger Basel 179 191
19. R. Miralbell, P. Coucke, F. Behroutz, N. Blazek, M. Melliger, and S. Philipp Nausea and vomiting in fractionated radiotherapy: a prospective on-demand trial of tropisetron rescue for non-responders to metoclopramide Eur J Cancer 31A 1995 1461 1464
20. H.G. Prentice, S. Cunningham, L. Gandhi, J. Cunningham, C. Collis, and M.D. Hamon Granisetron in the prevention of irradiation-induced emesis Bone Marrow Transplant 15 1995 445 448
21. S.G. Priestman, T.J. Priestman, and P.A. Canney A double-blind randomised cross-over comparison of nabilone and metoclopramide in the control of radiation-induced nausea Clin Radiol 38 1987 543 544
22. T.J. Priestman, J.T. Roberts, H. Lucraft, C.H. Collis, M. Adams, and B.K. Upadhyaya Results of a randomized, double-blind comparative study of ondansetron and metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation Clin Oncol 2 1990 71 75
23. T.J. Priestman, J.T. Roberts, and B.K. Upadhyaya A prospective randomized double-blind trial comparing ondansetron versus prochlorperazine for the prevention of nausea and vomiting in patients undergoing fractionated radiotherapy Clin Oncol 5 1993 358 363
24. J.T. Roberts Ondansetron in control of refractory emesis following radiotherapy Clin Oncol 4 1992 67 68
25. G.H. Sokol, H.M. Greenberg, S. McCarthy, L. Sledjessky, and G. Lyman Radiation induced nausea: the comparative efficacy of oral metoclopramide versus prochlorperazine and placebo. A double-blind randomized study Proc Am Soc Clin Oncol (ASCO) 5 1986 249
26. T.R. Spitzer, J.C. Bryson, E. Cirenza, R. Foelber, M. Wallerstadt, and C. Stout Randomized double-blind, placebo-controlled evaluation of oral ondansetron in the prevention of nausea and vomiting associated with fractionated total-body irradiation J Clin Oncol 12 1995 2432 2438
27. T.R. Spitzer, C.J. Friedman, W. Bushnell, S.R. Frankel, and J. Raschko Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation Bone Marrow Transplant 26 2000 203 210
28. A.J. Sykes, A.E. Kiltie, and A.L. Stewart Ondansetron versus chlorpromazine and dexamethasone combination for the prevention of nausea and vomiting: a prospective, randomised study to assess efficacy, cost effectiveness and quality of life following single-fraction radiotherapy Support Care Cancer 5 1997 500 503
29. The Italian Group for Antiemetic Research Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer N Engl J Med 332 1995 1 5
30. The Italian Group for Antiemetic Research in Radiotherapy Radiation-induced emesis: a prospective observational multicenter Italian trial Int J Radiat Oncol Biol Phys 44 1999 619 625
31. C. Tiley, R. Powles, J. Catalano, J. Treleaven, J. Eshelby, and M. Hewetson Results of a double blind placebo controlled study of ondansetron as an antiemetic during total body irradiation in patients undergoing bone marrow transplantation Leuk Lymphoma 7 1992 317 321
32. M.R. Tramer, D.J. Reynolds, N.S. Stoner, R.A. Moore, and H.J. McQuay Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting: a quantitative systematic review Eur J Cancer 34 1998 1836 1844
33. J.T. Ungerleider, T.A. Andrysiak, L.A. Fairbanks, A.S. Tesler, and R.G. Parker Tetrahydrocannabinol vs prochlorperazine. The effects of two antiemetics on patients undergoing radiotherapy Radiology 150 1984 598 599